Lixte shareholders elect all five directors, ratify auditor, approve stock plan increase

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

All five director nominees elected: Geordan Pursglove, Jason Sawyer, Dr. Michael Holloway, Lourdes Felix, Guy Primus.
Ratification of Weinberg & Company as auditor approved with 3,080,890 for, 36,370 against, 79 abstain.
Stock plan amendment to increase shares from 2.75M to 3.5M approved with 1,984,980 for, 74,134 against, 1,500 abstain.
Broker non-votes of ~1.06M on director elections and plan amendment.
Meeting had 3,117,339 shares present out of 5,635,467 shares entitled to vote.

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.